Cargando…

肺癌筛查领域指南方法学质量的系统评价

BACKGROUND AND OBJECTIVE: Lung cancer is the most common malignancy and screening can decrease the mortality. High quality screening guideline is necessary and important for effective work. Our study is to review and evaluate the basic characteristics and methodology quality of the current global lu...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973420/
https://www.ncbi.nlm.nih.gov/pubmed/27760601
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.11
_version_ 1783326628274765824
collection PubMed
description BACKGROUND AND OBJECTIVE: Lung cancer is the most common malignancy and screening can decrease the mortality. High quality screening guideline is necessary and important for effective work. Our study is to review and evaluate the basic characteristics and methodology quality of the current global lung cancer screening guidelines so as to provide useful information for domestic study in the future. METHODS: Electronic searches were done in English and Chinese databases including PubMed, the Cochrane Library, Web of Science, Embase, CNKI, CBM, Wanfang, and some cancer ofcial websites. Articles were screened according to the predefned inclusion and exclusion criteria by two researchers. Te quality of guidelines was assessed by AGREE Ⅱ. RESULTS: At last, a total of 11 guidelines with methodology were included. Te guidelines were issued mainly by USA (81%). Canada and China developed one, respectively. As for quality, the average score in the "Scale and objective" of all guidelines was 80, the average score in the "Participants" was 52, the average score in the "rigorism" was 50, the average score in the "clarity" was 76, the average score in the "application" was 43 and the average score in the "independence" was 59. Te highest average score was found in 2013 and 2015. Canada guideline had higher quality in six domains. 7 guidelines were evaluated as A level. CONCLUSION: Te number of clinical guidelines showed an increasing trend. Most guidelines were issued by developed countries with heavy burden. Multi-country contribution to one guideline was another trend. Evidencebased methodology was accepted globally in the guideline development.
format Online
Article
Text
id pubmed-5973420
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59734202018-07-06 肺癌筛查领域指南方法学质量的系统评价 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Lung cancer is the most common malignancy and screening can decrease the mortality. High quality screening guideline is necessary and important for effective work. Our study is to review and evaluate the basic characteristics and methodology quality of the current global lung cancer screening guidelines so as to provide useful information for domestic study in the future. METHODS: Electronic searches were done in English and Chinese databases including PubMed, the Cochrane Library, Web of Science, Embase, CNKI, CBM, Wanfang, and some cancer ofcial websites. Articles were screened according to the predefned inclusion and exclusion criteria by two researchers. Te quality of guidelines was assessed by AGREE Ⅱ. RESULTS: At last, a total of 11 guidelines with methodology were included. Te guidelines were issued mainly by USA (81%). Canada and China developed one, respectively. As for quality, the average score in the "Scale and objective" of all guidelines was 80, the average score in the "Participants" was 52, the average score in the "rigorism" was 50, the average score in the "clarity" was 76, the average score in the "application" was 43 and the average score in the "independence" was 59. Te highest average score was found in 2013 and 2015. Canada guideline had higher quality in six domains. 7 guidelines were evaluated as A level. CONCLUSION: Te number of clinical guidelines showed an increasing trend. Most guidelines were issued by developed countries with heavy burden. Multi-country contribution to one guideline was another trend. Evidencebased methodology was accepted globally in the guideline development. 中国肺癌杂志编辑部 2016-10-20 /pmc/articles/PMC5973420/ /pubmed/27760601 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.11 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
肺癌筛查领域指南方法学质量的系统评价
title 肺癌筛查领域指南方法学质量的系统评价
title_full 肺癌筛查领域指南方法学质量的系统评价
title_fullStr 肺癌筛查领域指南方法学质量的系统评价
title_full_unstemmed 肺癌筛查领域指南方法学质量的系统评价
title_short 肺癌筛查领域指南方法学质量的系统评价
title_sort 肺癌筛查领域指南方法学质量的系统评价
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973420/
https://www.ncbi.nlm.nih.gov/pubmed/27760601
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.11
work_keys_str_mv AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià
AT fèiáishāichálǐngyùzhǐnánfāngfǎxuézhìliàngdexìtǒngpíngjià